1. Home
  2. RDFN vs EVO Comparison

RDFN vs EVO Comparison

Compare RDFN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDFN
  • EVO
  • Stock Information
  • Founded
  • RDFN 2002
  • EVO 1993
  • Country
  • RDFN United States
  • EVO Germany
  • Employees
  • RDFN N/A
  • EVO N/A
  • Industry
  • RDFN Real Estate
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDFN Finance
  • EVO Health Care
  • Exchange
  • RDFN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RDFN 1.3B
  • EVO 1.4B
  • IPO Year
  • RDFN 2017
  • EVO 2021
  • Fundamental
  • Price
  • RDFN $11.24
  • EVO $3.76
  • Analyst Decision
  • RDFN Hold
  • EVO Buy
  • Analyst Count
  • RDFN 11
  • EVO 2
  • Target Price
  • RDFN $10.85
  • EVO $5.90
  • AVG Volume (30 Days)
  • RDFN 6.4M
  • EVO 159.9K
  • Earning Date
  • RDFN 08-05-2025
  • EVO 08-13-2025
  • Dividend Yield
  • RDFN N/A
  • EVO N/A
  • EPS Growth
  • RDFN N/A
  • EVO N/A
  • EPS
  • RDFN N/A
  • EVO N/A
  • Revenue
  • RDFN $1,038,527,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • RDFN N/A
  • EVO $10.08
  • Revenue Next Year
  • RDFN $5.32
  • EVO $10.99
  • P/E Ratio
  • RDFN N/A
  • EVO N/A
  • Revenue Growth
  • RDFN 5.11
  • EVO 1.50
  • 52 Week Low
  • RDFN $5.49
  • EVO $2.84
  • 52 Week High
  • RDFN $15.29
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RDFN 64.56
  • EVO 41.37
  • Support Level
  • RDFN $10.29
  • EVO $4.06
  • Resistance Level
  • RDFN $11.09
  • EVO $4.44
  • Average True Range (ATR)
  • RDFN 0.50
  • EVO 0.11
  • MACD
  • RDFN 0.06
  • EVO -0.04
  • Stochastic Oscillator
  • RDFN 91.98
  • EVO 0.00

About RDFN Redfin Corporation

Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: